Astrazeneca (AZN)


AZN Share PerformanceMore

52 week high5,520.0 22/06/17
52 week low3,996.0 06/12/16
52 week change -599.0 (-11.87%)
4 week volume59,565,876 24/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

FTSE slumps as airlines remain weak

Weakness in cigarette sellers and airlines continued to weigh on the FTSE 100, which finished Friday down 0.8% at 7,323. Im...

Tragic terror attack weighs on airlines

Thursday's terror attack in Barcelona unnerved the market and caused a slump in airlines, including British Airways own...

FTSE falls after Barcelona terror attack

The FTSE 100 fell 0.62% to 7,342.42 on Friday morning following Thursday's terror attack in Barcelona, which hurt US an...

AZ-Merck's Lynparza gets US approval for ovarian cancer

AstraZeneca and Merck & Co have announced that Lynparza has received additional and broad approval in the US for ov...

Lynparza gets broad FDA approval in ovarian cancer

RNS Number: 3479O AstraZeneca PLC 18 August 2017 This announcement contains inside information 18 August 2017 07:00 BST LYNPARZA RECEIVES ADDITIONAL AND BROAD APPROVAL IN THE US FOR OVARIAN CANCER Lynparza's new tablet formulation approved as maintenance treatment for women with platinum-sensitive recurrent ovarian ...

AstraZeneca non-exec to step down

AstraZeneca non-executive director Bruce Burlington will retire on 31 August. He is a member of the audit, the nomination...

Directorate Change

RNS Number: 0963O AstraZeneca PLC 16 August 2017 16 August 2017 07:00 BST ASTRAZENECA NON-EXECUTIVE DIRECTOR RETIREMENT AstraZeneca announced that, on 31 August 2017, Bruce Burlington will retire as a Non-Executive Director of AstraZeneca PLC and as a member of the Audit Committee, the Nomination and Governance Committee, an...

Holding(s) in Company

RNS Number: 9312N AstraZeneca PLC 14 August 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: AstraZeneca PLC 1b....

Latest discussion posts More

  • Telegraph article

    The US Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca and Merck, to include ongoing treatment of patients with recurrent ovarian ...
    Proverbs 26 vs 5
  • Re: +91p today, I wonder why

    I don't think that it would be Pfizer. IF someone is showing an interest my money (a lot of it) would be on Novartis,
    Proverbs 26 vs 5
  • Re: +91p today, I wonder why

    Phizer sniffing around ??

Users' HoldingsMore

Users who hold Astrazeneca also hold..

Codes & Symbols